Author

A. B. Shuaibu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. A. Adamu· 1 shared A. Y. Bello· 1 shared A. Yunusa· 1 shared C. L. Ochu· 1 shared E. U. Igumbor· 1 shared I. Okoye· 1 shared M. A. Popoola· 1 shared M. B. Bello· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. A. Adamu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Innovative, rapid, high throughput method for drug repurposing in a pandemic - a case study of SARS-CoV-2 and COVID-19

S. O. Bello, A. Yunusa, A. A. Adamu, M. U. Imam, M. B. Bello, A. B. Shuaibu, E. U. Igumbor, Z. G. Habib, M. A. Popoola, C. L. Ochu, A. Y. Bello, Y. Y. Deeni, I. Okoye

This study identifies potential drugs for COVID-19 by combining computational and wet-lab methods, finding that erythromycin, pyridoxine, folic acid, and retapamulin inhibit SARS-CoV-2 induced cytopathic effect in Vero cells at clinically achievable concentrations.

bioRxiv · Dec 25, 2022Pharmacology & Toxicology